<!DOCTYPE frameset SYSTEM "frameset.dtd">
<frameset>
  <predicate lemma="transfect">
    <roleset id="transfect.01" name="introduce nucleic acids into a recipient cell" >
      <aliases>
        <alias framenet="" pos="v" verbnet="">transfect</alias>
        <alias framenet="" pos="n" verbnet="">transfection</alias>
      </aliases>
      <roles>
        <role descr="intentional agent of transfection (e.g. scientist)" f="pag" n="0" />
        <role descr="recipient of transfection (e.g. cell)" f="ppt" n="1" />
        <role descr="entity inserted into the cell (e.g. nucleid acid)" f="ppt" n="2" />
        <note>For Bio-AMR annotations.</note>
      </roles>
      <example name="example with agent" src="" type="">
        <text>To establish that the cloned protein displays serine racemase activity, we transfected HEK293 cells that do not possess endogenous D-serine.</text>
        <arg f="" n="0">we</arg>
	<rel f="">transfected</rel>
        <arg f="" n="1">HEK293 cells that do not possess endogenous D-serine</arg>
      </example>
      <example name="example with instrument" src="" type="">
        <text>In cells transfected with wild-type EGFR, MEK inhibition led to feedback activation of phospho-ERBB3 and phosho-EGFR, recapitulating the results we had observed in our panel of cancer cell lines (Figure 6A).</text>
        <arg f="" n="1">cells</arg>
	<rel f="">transfected</rel>
        <arg f="" n="2">wild-type EGFR</arg>
      </example>
    </roleset>
  </predicate>
</frameset>
